EIF-2 kinase modulator

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

MYD88 mutation	Diffuse Large B Cell Lymphoma	MYD88 mutation	Diffuse Large B Cell Lymphoma	BTM-3566 Sensitive: D – Preclinical BTM-3566 Sensitive : D	BTM-3566 Sensitive: D – Preclinical BTM-3566 Sensitive : D
MYC rearrangement + BCL2 rearrangement	Diffuse Large B Cell Lymphoma	MYC rearrangement + BCL2 rearrangement	Diffuse Large B Cell Lymphoma	BTM-3566 Sensitive: D – Preclinical BTM-3566 Sensitive : D	BTM-3566 Sensitive: D – Preclinical BTM-3566 Sensitive : D

Associations(2)